These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Evidence for shortening the duration of clinical trials of antidepressants and a proposed paradigm for such studies. Katz MM; Berman N; Bowden CL; Frazer A J Clin Psychopharmacol; 2015 Jun; 35(3):329-32. PubMed ID: 25874919 [TBL] [Abstract][Full Text] [Related]
27. Problems in the Descriptions of the Psychiatric Inclusion and Exclusion Criteria in Publications of Antidepressant Efficacy Trials: A Qualitative Review and Recommendations for Improved Clarity. Zimmerman M; Multach M; Walsh E; Rosenstein LK; Gazarian D; Clark HL CNS Drugs; 2016 Mar; 30(3):185-91. PubMed ID: 26818632 [TBL] [Abstract][Full Text] [Related]
28. Drugs: guide and caveats to explanatory and descriptive approaches--II. Drugs in psychiatric research. Bollini P; Cotecchia S; De Blasi A; Romandini S; Tognoni G J Psychiatr Res; 1984; 18(4):391-400. PubMed ID: 6595401 [TBL] [Abstract][Full Text] [Related]
29. Clinical experience and a double-blind study of a new anti-depressant, vivactil hydrochloride. Daneman EA Psychosomatics; 1965; 6(5):342-6. PubMed ID: 5319247 [No Abstract] [Full Text] [Related]
30. Mental health services research: moving from academia to the community. Callahan CM; Hendrie HC Am J Geriatr Psychiatry; 2010 Jun; 18(6):460-3. PubMed ID: 21217557 [No Abstract] [Full Text] [Related]
31. Geriatric psychopharmacology. Small GW West J Med; 1989 Sep; 151(3):312-3. PubMed ID: 18750637 [No Abstract] [Full Text] [Related]
32. Retrospective cohort study of venlafaxine, fluoxetine or sertraline in long-term care. Blake LM; Wan GJ; Panish JM; Buatti MC Clin Drug Investig; 2003; 23(11):735-42. PubMed ID: 17536887 [TBL] [Abstract][Full Text] [Related]
34. Antidepressants in the elderly: challenges for study design and their interpretation. Parikh C Br J Clin Pharmacol; 2000 Jun; 49(6):539-47. PubMed ID: 10848717 [TBL] [Abstract][Full Text] [Related]
35. Choosing appropriate antidepressant therapy in the elderly. A risk-benefit assessment of available agents. Flint AJ Drugs Aging; 1998 Oct; 13(4):269-80. PubMed ID: 9805208 [TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics of sertraline and its N-demethyl metabolite in elderly and young male and female volunteers. Ronfeld RA; Tremaine LM; Wilner KD Clin Pharmacokinet; 1997; 32 Suppl 1():22-30. PubMed ID: 9068932 [TBL] [Abstract][Full Text] [Related]
37. Clinical pharmacokinetics of antidepressants in the elderly. Therapeutic implications. von Moltke LL; Greenblatt DJ; Shader RI Clin Pharmacokinet; 1993 Feb; 24(2):141-60. PubMed ID: 8471078 [TBL] [Abstract][Full Text] [Related]
38. Psychotropic drugs, aging and community care. Philpot M; Puranik A Drugs Aging; 1994 Oct; 5(4):235-41. PubMed ID: 7827394 [No Abstract] [Full Text] [Related]
39. Effects of antidepressants on cognitive functioning of elderly patients. A review. Knegtering H; Eijck M; Huijsman A Drugs Aging; 1994 Sep; 5(3):192-9. PubMed ID: 7803947 [TBL] [Abstract][Full Text] [Related]
40. Problems and pitfalls in the use of benzodiazepines in the elderly. Kruse WH Drug Saf; 1990; 5(5):328-44. PubMed ID: 2222867 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]